Saturday 17 October 2026
Export AMRN’s income statement to Excel — free account
Amarin Corporation PLC
AMRN Healthcare Drug Manufacturers General
Amarin Corporation PLC’s revenue for fiscal 2025 (year ended December 2025) was $213.6 million, down 6.55% from fiscal 2024. In the quarter to June 2026, revenue fell 42.0%, EPS grew 45.8% and free cash flow fell 60.2%, each against the same quarter a year earlier.
11.37
0.20
−1.73%
Follow AMRN
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 130.22 | 0.00 | 0.00 | 0.00 | 0.00 |
Piotroski F-Score |
5 | 4 | 4 | 5 | 3 | 4 | 2 | 5 | 3 | 7 |
Altman Z-Score |
(7.88) | (7.62) | 5.72 | 15.08 | 2.52 | 1.28 | (0.81) | (1.14) | (2.18) | (1.86) |
P/S ratio |
5.03 | 6.34 | 17.65 | 17.09 | 3.04 | 2.29 | 1.29 | 1.18 | 0.88 | 1.36 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 52.92 | 0.00 | 43.21 |
Altman Z″-Score (non-manufacturers) |
(23.45) | (26.04) | (9.18) | 1.49 | 0.87 | 0.59 | (1.09) | (1.02) | (2.30) | (2.07) |
Beneish M-Score |
(2.43) | (2.90) | (2.48) | (1.37) | (1.36) | (1.73) | (1.95) | (2.86) | (2.52) | (3.26) |
P/Operating CF |
(33.90) | (536.25) | (125.23) | (821.85) | (48.71) | (47.26) | 307.59 | (562.50) | (15.13) | 18.96 |
P/B ratio |
0.00 | 0.00 | 31.00 | 12.52 | 2.98 | 2.00 | 0.80 | 0.66 | 0.41 | 0.63 |
Price to Tangible BV |
0.00 | 0.00 | 32.89 | 12.86 | 3.04 | 2.07 | 0.83 | 0.68 | 0.43 | 0.65 |
EV/Sales |
5.17 | 6.60 | 16.91 | 15.72 | 2.25 | 1.53 | 0.50 | 0.20 | (0.33) | 0.02 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 66.98 | 0.00 | 0.00 | 0.84 | 0.00 |
EV/Operating CF |
(9.36) | (36.42) | (40.92) | (721.21) | (63.47) | (13.45) | (1.03) | 8.72 | 2.41 | 0.77 |
EV/FCF |
(9.36) | (36.41) | (40.89) | (570.08) | (62.75) | (13.45) | (1.03) | 8.75 | 2.41 | 0.78 |
Quick Ratio |
1.56 | 1.10 | 2.02 | 3.16 | 2.14 | 1.68 | 1.70 | 1.75 | 2.32 | 2.21 |
Current Ratio |
1.92 | 1.41 | 2.40 | 3.53 | 2.86 | 2.37 | 2.66 | 2.80 | 3.31 | 3.34 |
Net Debt/EBITDA |
(0.31) | (1.14) | 1.62 | 29.78 | 29.73 | (34.29) | 3.02 | 4.97 | 3.32 | 6.42 |
Debt/Assets |
69.73% | 75.90% | 20.83% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
(12.86) | (1.88) | 0.53 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.76 | 1.10 | 0.84 | 0.68 | 0.66 | 0.57 | 0.38 | 0.36 | 0.30 | 0.32 |
Operating CF/Net income |
0.83 | 0.48 | 0.81 | 0.41 | 1.21 | (8.61) | 1.70 | (0.12) | 0.38 | (0.17) |
Capex/Depreciation |
0.00 | 0.00 | (0.02) | (0.99) | (0.09) | 0.00 | 0.00 | (0.01) | 0.00 | 0.00 |
Interest Coverage |
(3.51) | (4.66) | (12.20) | (3.66) | (7.55) | 81.41 | (7,057.93) | (8,448.50) | (13,113.86) | (7,167.14) |
| 93.18% | 110.45% | (567.80%) | (6.32%) | (2.97%) | 1.19% | (16.76%) | (10.30%) | (15.83%) | (8.21%) | |
| (50.76%) | (41.31%) | (42.55%) | (3.57%) | (1.95%) | 0.76% | (10.83%) | (6.88%) | (10.83%) | (5.72%) | |
ROIC |
(480.23%) | 0.00% | 0.00% | 0.00% | (10.02%) | 3.14% | (23.18%) | (18.29%) | (29.94%) | (20.04%) |
Return on Tangible Assets |
(123.08%) | (151.59%) | (52.74%) | (3.68%) | (3.14%) | 1.52% | (24.58%) | (12.69%) | (19.78%) | (8.52%) |
Average Days of Receivables |
56.08 | 91.33 | 105.93 | 98.89 | 91.88 | 102.43 | 129.50 | 158.84 | 195.23 | 216.68 |
Research and Development Expense of Revenue |
38.42% | 26.04% | 24.39% | 8.00% | 6.34% | 5.03% | 8.24% | 7.24% | 9.13% | 9.27% |
Selling, General and Administrative Expense of Revenue |
85.62% | 74.29% | 99.03% | 75.30% | 75.45% | 70.02% | 82.45% | 65.15% | 66.62% | 53.83% |
Intangible Assets out of Total Assets |
0.05 | 0.05 | 0.02 | 0.02 | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
Share Based Compensation of Revenue |
10.46% | 7.71% | 8.20% | 7.19% | 7.46% | 6.33% | 7.10% | 5.10% | 7.74% | 6.52% |
Graham Net Nets |
(0.05) | (0.06) | 0.04 | 0.08 | 0.29 | 0.36 | 0.83 | 1.23 | 1.97 | 1.51 |
Graham Number |
24.13 | 27.27 | 0.00 | 0.00 | 0.00 | 19.81 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(13.27%) | (5.90%) | (2.87%) | (0.31%) | (1.23%) | 0.77% | (22.69%) | (16.20%) | (40.06%) | (13.39%) |
Free Cash Flow Yield |
(10.97%) | (2.86%) | (2.34%) | (0.16%) | (1.18%) | (4.99%) | (37.72%) | 1.89% | (15.42%) | 2.31% |
Revenue per Share |
12.28 | 13.38 | 15.42 | 25.09 | 32.17 | 29.45 | 18.41 | 15.06 | 11.13 | 10.30 |
Operating CF per Share |
(6.78) | (2.43) | (6.37) | (0.55) | (1.14) | (3.36) | (8.98) | 0.34 | (1.51) | 0.32 |
Capex per Share |
0.00 | 0.00 | 0.00 | (0.14) | (0.01) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Free Cash Flow per Share |
(6.78) | (2.43) | (6.38) | (0.69) | (1.15) | (3.36) | (8.98) | 0.34 | (1.51) | 0.32 |
Cash per Share |
9.33 | 5.49 | 16.87 | 37.86 | 26.45 | 23.13 | 15.45 | 15.76 | 14.33 | 14.59 |
Shareholders Equity per Share |
(0.85) | (4.81) | 10.25 | 35.52 | 32.87 | 33.69 | 29.68 | 27.09 | 23.66 | 22.13 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(0.85) | (4.81) | 10.25 | 35.52 | 32.87 | 33.69 | 29.68 | 27.09 | 23.66 | 22.13 |
Free Cash Flow |
(71.84) | (32.85) | (94.76) | (11.84) | (22.00) | (66.53) | (180.09) | 6.86 | (31.02) | 6.73 |
Working Capital |
70.08 | 44.74 | 220.73 | 612.76 | 571.79 | 508.05 | 429.62 | 465.70 | 415.45 | 455.42 |
Capital Expenditures |
(0.02) | (0.01) | (0.06) | (2.48) | (0.25) | 0.00 | (0.60) | (0.02) | — | — |
Net Current Asset Value |
(29.73) | (73.43) | 144.61 | 581.06 | 540.72 | 477.76 | 398.25 | 445.39 | 396.23 | 438.39 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 85.20 | 0.00 | 0.00 | 0.82 | 0.00 |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 127.07 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
109.82 | 108.57 | 45.27 | 1.06 | 1.33 | 2.00 | 3.54 | 26.01 | 188.31 | 252.33 |
Cash ROIC |
(34.83%) | (24.92%) | (19.60%) | (0.94%) | (1.94%) | (5.91%) | (19.89%) | 0.79% | (3.97%) | 0.88% |
Accounts Receivable Turnover |
7.69 | 5.55 | 4.10 | 4.70 | 4.53 | 3.67 | 2.51 | 2.32 | 1.79 | 1.72 |
Accounts Payable Turnover |
4.07 | 2.88 | 1.74 | 2.19 | 1.69 | 1.10 | 1.41 | 2.41 | 3.16 | 2.16 |
Inventory Turnover |
1.74 | 1.77 | 1.24 | 1.43 | 0.99 | 0.57 | 0.55 | 0.58 | 0.69 | 0.51 |
Average Days of Payables |
64.39 | 204.25 | 251.83 | 189.88 | 294.00 | 345.73 | 186.09 | 136.23 | 100.07 | 178.43 |
Days of Inventory on Hand |
217.82 | 245.70 | 386.81 | 291.82 | 524.45 | 706.00 | 658.89 | 667.71 | 411.65 | 770.73 |
Average Receivables |
16.91 | 32.65 | 55.92 | 91.48 | 135.50 | 159.11 | 147.32 | 132.28 | 127.92 | 124.56 |
Average Payables |
8.45 | 15.61 | 31.39 | 43.79 | 77.91 | 110.40 | 89.76 | 58.68 | 46.56 | 42.86 |
Average Inventory |
19.75 | 25.38 | 44.03 | 67.29 | 132.82 | 211.77 | 231.70 | 243.67 | 212.33 | 180.98 |
Average Assets |
170.11 | 164.30 | 273.66 | 633.96 | 924.12 | 1,017.04 | 977.12 | 858.93 | 758.52 | 678.06 |
Average Common Equity |
(92.67) | (61.44) | 20.51 | 358.45 | 606.96 | 647.30 | 631.22 | 573.72 | 519.14 | 472.73 |
Columns are period end dates